ZimVie (NASDAQ:ZIMV - Get Free Report) released its earnings results on Wednesday. The company reported $0.27 EPS for the quarter, beating the consensus estimate of $0.25 by $0.02, Zacks reports. ZimVie had a negative net margin of 77.31% and a positive return on equity of 2.90%. The company had revenue of $111.52 million for the quarter, compared to analyst estimates of $113.67 million. ZimVie updated its FY 2025 guidance to 0.800-0.950 EPS.
ZimVie Trading Up 3.0 %
Shares of ZIMV stock traded up $0.39 on Friday, hitting $13.27. 112,015 shares of the company's stock traded hands, compared to its average volume of 243,368. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.38 and a current ratio of 1.94. ZimVie has a one year low of $12.25 and a one year high of $22.40. The company's fifty day simple moving average is $13.75 and its 200 day simple moving average is $14.72. The stock has a market capitalization of $367.27 million, a price-to-earnings ratio of -1.01 and a beta of 2.10.
Wall Street Analyst Weigh In
Separately, Needham & Company LLC reaffirmed a "buy" rating and set a $23.00 target price on shares of ZimVie in a report on Thursday.
Check Out Our Latest Report on ZIMV
About ZimVie
(
Get Free Report)
ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.
Featured Stories
Before you consider ZimVie, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ZimVie wasn't on the list.
While ZimVie currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
